These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2516585)

  • 1. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW; Li PK
    Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y; Schneider MR; Michna H; el Etreby MF
    J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer.
    Brodie AM; Schwarzel WC; Shaikh AA; Brodie HJ
    Endocrinology; 1977 Jun; 100(6):1684-95. PubMed ID: 404132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors--IV. Regression of hormone-dependent, mammary tumors in the rat with 4-acetoxy-4-androstene-3,17-dione.
    Brodie AM; Marsh D; Brodie HJ
    J Steroid Biochem; 1979 Apr; 10(4):423-9. PubMed ID: 109701
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitumor effects of SEF19, a new nonsteroidal aromatase inhibitor, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Iino Y; Karakida T; Sugamata N; Andoh T; Takei H; Takahashi M; Yaguchi S; Matsuno T; Takehara M; Sakato M; Kawashima S; Morishita Y
    Anticancer Res; 1998; 18(1A):171-6. PubMed ID: 9568073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY; Garrett WM; Brodie AM
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.
    Spinola PG; Marchetti B; Mérand Y; Bélanger A; Labrie F
    Breast Cancer Res Treat; 1988 Dec; 12(3):287-96. PubMed ID: 3147727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an aromatase inhibitor, 1,4,6-androstatriene-3,17-dione, on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat and its mechanism of action in vivo.
    Brodie AM; Brodie HJ; Garrett WM; Hendrickson JR; Marsh DA; Tsai-Morris CH
    Biochem Pharmacol; 1982 Jun; 31(11):2017-23. PubMed ID: 6810900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effect of the new aromatase inhibitor fadrozole on pre- and postmenopausal models of rat mammary tumor.
    Tanaka M; Yano S; Hasegawa Y; Nakao K
    Arzneimittelforschung; 1994 Jun; 44(6):774-8. PubMed ID: 8053980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androstenedione and androst-5-ene-3 beta,17 beta-diol stimulate DMBA-induced rat mammary tumors--role of aromatase.
    Dauvois S; Labrie F
    Breast Cancer Res Treat; 1989 Jan; 13(1):61-9. PubMed ID: 2495831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects of a nonsteroidal aromatase inhibitor (CGS 16949A) on 7, 12-dimethylbenz[alpha]anthracene-induced mammary tumors in rats.
    Iino Y; Sugamata N; Owada S; Tago T; Sato H; Yokoe T; Maemura M; Morishita Y; Horiuchi R
    Jpn J Clin Oncol; 1991 Jun; 21(3):153-9. PubMed ID: 1834875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
    Zhou JL; Brodie A
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Sugamata N; Koibuchi Y; Iino Y; Morishita Y
    Int J Oncol; 1999 Feb; 14(2):259-63. PubMed ID: 9917500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.